# NAD+: Research Overview — Pure Core Peptides > A plain-English and cited literature summary of NAD+, the cellular redox coenzyme behind NMN and NR supplements. Covers mechanism, human trial evidence, and open safety questions. A coenzyme every living cell relies on to turn food into usable energy — and the reason so many people are trying to top their levels back up as they get older. ## The short version NAD+ is not a lab-made peptide like the other compounds on this guide — it is a molecule every single cell in the body already makes and cannot survive without. Its main job is acting like a rechargeable battery for metabolism: cells use it to shuttle the energy released from food into a usable form, and they also use it up as fuel for repair and maintenance jobs like fixing damaged DNA. The reason NAD+ shows up constantly in research-peptide and longevity conversations is simple: tissue levels of it measurably decline with age. That has led to a wave of interest in "NAD+ boosting" — through direct NAD+ supplements, precursor molecules like NMN and NR, or IV infusions. The honest state of the science, covered below, is that raising blood NAD+ is well established; proving that raising it changes a real health outcome in people is still a work in progress. ## What it is NAD+, short for nicotinamide adenine dinucleotide, is built from two smaller pieces — a nicotinamide unit and an adenine unit — joined by a bridge of two phosphate groups. It exists in two interconvertible forms: an oxidized form (NAD+) and a reduced form (NADH), and cells constantly flip between the two as part of normal metabolism. Two other names show up often in this space: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside), both of which are smaller "precursor" molecules the body converts into NAD+ after absorption — the rationale being that oral NAD+ itself is poorly taken up by cells intact, so most researchers focus on these precursors instead. ## How it works NAD+ has two separate jobs inside a cell. The first is as a redox carrier — a molecule that ferries electrons through the chemical steps (glycolysis, the TCA cycle, and the mitochondria's power-generating machinery) that turn food into ATP, the energy currency cells actually spend. The second job is as a substrate: a group of enzymes, including sirtuins (involved in gene regulation and stress response) and PARPs (involved in repairing damaged DNA), consume NAD+ directly to do their work. A third enzyme, CD38, also consumes NAD+ and appears to become more active with age, which is one leading explanation for why NAD+ levels fall over time — there is simply more of an enzyme around competing to use it up [9][11]. ## What the research shows *Human review of the evidence (2025).* A comprehensive review of NAD+ precursor trials in aging concluded that human studies have shown limited efficacy so far, that age-related NAD+ decline itself has only been directly observed in a handful of human studies, and that far more tissue-specific (rather than just blood) data is needed before drawing firm conclusions [6]. This is the most current expert synthesis of where the human evidence actually stands. *NMN raises blood NAD+ and improved walking distance.* In a multicenter, placebo-controlled trial in middle-aged adults, 60 days of oral NMN (300-900 mg per day) raised blood NAD+ in a dose-dependent way and improved walking distance and quality-of-life scores compared with placebo, with 600 mg per day identified as the best-performing dose and no safety concerns at any dose tested [7]. *NMN and insulin sensitivity.* In prediabetic, postmenopausal women, 10 weeks of oral NMN (250 mg per day) measurably improved how sensitive muscle tissue was to insulin, though it did not change body composition or long-term blood-sugar averages [8]. *NR raises blood NAD+ in a dose-dependent way.* In healthy overweight adults, 8 weeks of nicotinamide riboside at 100, 300, and 1,000 mg per day raised whole-blood NAD+ by 22%, 51%, and 142% respectively, without causing flushing or any meaningful difference in side effects from placebo [10]. *Mouse data on the aging mechanism.* Removing the CD38 enzyme in mice protects them from the usual age-related drop in NAD+ and preserves mitochondrial function — supporting CD38 as a key driver of the decline [11]. *Heart-failure research.* In a 2025 study combining human heart tissue and a mouse model of a common form of heart failure, restoring NAD+ activated a fat-burning enzyme in heart muscle and improved heart function — an effect that disappeared when that enzyme was removed, tying the benefit specifically to that pathway [12]. ## Reported effects, cautions & safety There is no verified community-report dataset for NAD+ in this guide's source material, so instead of anecdotal patterns, this section leans directly on the published cautions and open questions in the research literature. - **Efficacy is still unsettled.** A 2025 review found human trials of NAD+ precursors have shown limited efficacy so far, and cautioned against over-relying on rodent studies that do not always translate to people [6]. - **Oral NAD+ itself may not do much.** Many researchers consider plain oral NAD+ capsules poorly absorbed intact by cells, which is why most current research focuses on precursor molecules like NMN and NR instead. - **IV and injectable NAD+ carry their own risks.** "NAD+ IV therapy" is marketed widely by wellness clinics on comparatively thin controlled evidence, and infusions run too quickly have been linked to chest or abdominal discomfort, flushing, and nausea. Compounded injectable NAD+ has also been the subject of a regulatory recall over bacterial contamination concerns. - **A theoretical cancer question.** Because NAD+ supports the metabolism of any rapidly dividing cell, including cancer cells, some researchers flag a theoretical concern about boosting it in people with an active or recent malignancy — this is a mechanism-based caution, not a demonstrated harm. - **Regulatory status is unsettled for NMN specifically.** In the United States, NMN's status as a dietary supplement has been challenged on the grounds that it was first investigated as a drug, creating real marketplace uncertainty about what is and is not legally sold as a supplement. - **Product quality varies.** Supplement-grade NAD+, NMN, and NR products differ widely in purity and actual content, and third-party testing is not guaranteed across brands. ## Where it fits in Research Peptide Fundamentals NAD+ is the compound most readers land on first, and it sits in the middle of this guide's regulatory spectrum: further along than a pure research chemical like [Ipamorelin](/ipamorelin), but nowhere near as thoroughly proven in human trials as the approved drugs [Semaglutide](/semaglutide) and [Tesamorelin](/tesamorelin). Its appeal is universal — every cell needs it — which is exactly why the evidence question (does raising it change a real outcome, not just a blood number) matters so much. See how all four compare on the [comparison page](/compare). ![NAD+ research illustration — abstract cool scientific motif](/images/nad.webp) --- Think of this as a friendly explainer, not a doctor's office — we translate the research into plain language and leave prescribing to licensed clinicians.